Abiopharma

Dave & Buster’s Entertainment, Inc. to Report First Quarter 2026 Financial Results on June 15, 2026

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zeta Global Announces Olympic Gold Medalist, Entrepreneur and Founder Lindsey Vonn as Second Zeta Live 2026 Keynote Speaker

Sonos Announces Participation in Rosenblatt’s 6th Annual Technology Virtual Summit

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

BGC Group to Present at the Piper Sandler Global Exchange & FinTech Conference on June 4, 2026

HPE Reports Fiscal 2026 Second Quarter Results

Agilysys to Participate in the William Blair 46th Annual Growth Stock Conference